The GMP certification for the company’s production facilities has added to its portfolio of international approvals from 25 regulators
Venus Remedies has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in the production of injectable pharmaceuticals, including oncology, antibiotic and anticoagulant medications.
Saransh Chaudhary, CEO, Venus Medicine Research Centre, said, “The GMP certification from Libya adds to Venus Remedies’ portfolio of international approvals from 25 regulators, complementing our existing certifications in Africa from Morocco, South Africa, Tanzania, Kenya, Uganda, Sudan and other African countries. This GMP certification reflects our collaborative efforts in the African pharmaceutical industry, a key focus area of our global expansion strategy.”
Lauding the achievement, Akshansh Chaudhary, Executive Director of Venus Remedies, said, “We are thankful to our customers, partners and stakeholders for their constant support. Their trust in our company drives our pursuit of excellence.”
